Aurora Cannabis ACB stock analysis and is ACB stock a good buy at this price?

Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline

Astellas Pharma president and CEO Naoki Okamura Astellas Pharma has agreed to acquire Iveric Bio for approximately $5.9 billion, the companies said today, in a

May 1, 2023

Califf lays out drug shortage landscape, talks post-market data collection for accelerated approvals

Efforts to inspect generic drug facilities around the world could end up worsening US shortages of several key medicines if they lead to halted manufacturing,

February 29, 2024

UW research contradicts Musk’s vision of high-resolution implants

Elon Musk recently declared on X that Blindsight, a cortical implant to restore vision, would have low resolution at first “but may ultimately exceed normal

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.